B1 Vertaisarvioitu muu artikkeli (esim. pääkirjoitus, letter, comment) tieteellisessä lehdessä

Perfluorohexyloctane: More than Meets the Eye?



Tekijät: Alijagic, Andi; Oresic, Matej; Hyötyläinen, Tuulia

Julkaisuvuosi: 2026

Lehti: Chemical Research in Toxicology

Artikkelin numero: acs.chemrestox.5c00507

Vuosikerta: 39

Numero: 2

Aloitussivu: 205

Lopetussivu: 207

ISSN: 0893-228X

eISSN: 1520-5010

DOI: https://doi.org/10.1021/acs.chemrestox.5c00507

Julkaisun avoimuus kirjaamishetkellä: Avoimesti saatavilla

Julkaisukanavan avoimuus : Osittain avoin julkaisukanava

Verkko-osoite: https://doi.org/10.1021/acs.chemrestox.5c00507

Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/509005127

Rinnakkaistallenteen lisenssi: CC BY

Rinnakkaistallennetun julkaisun versio: Kustantajan versio


Tiivistelmä

Perfluorohexyloctane (F6H8) is a semifluorinated alkane increasingly used in medical applications. Emerging evidence, however, indicates that this compound can persist in biological systems and influence cellular processes. These observations suggest that the exceptional stability of F6H8, while beneficial for medical performance, may also have implications for long-term biological and health outcomes.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

Julkaisussa olevat rahoitustiedot: 
The authors acknowledge the "Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease" (EDC-MASLD) consortium funded by the Horizon Europe Program of the European Union under Grant Agreement 101136259. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.


Last updated on